Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: hm who wrote (5544)	1/25/2002 7:54:26 AM
From: DNA-Jock	Read Replies (1) of 52153

To return to the more general question of the usefulness of information from PR's, conferences, and publications - hm wrote "[peer-reviewed disclosure] may be the only standard for an academic. And even that standard has many flaws as anybody who has been involved in the process knows. " How true. Both for conference presentations and for journal articles. But the great benefit of a journal article is that it should contain all the data to allow an assessment of whether the technology works, or not. You can usually spot a crock. Recognize that article > presentation > PR, and befriend a researcher....

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next